Novel insights and interventions to reduce healthcare-associated infections

19:15 • 143 • Synbiotic therapy prevents nosocomial infection in critically ill adult patients: a systematic review and network meta-analysis of randomised controlled trials based on a bayesian framework > L. Li CONG (Nanjing) 19:25 • 798 • Effect of <em>Lactobacillus</em> <em>rhamnosus</em> on eradication of Vancomycin-Resistant <em>Enterococcus faecium</em> (VREfm) in non-symptomatic VREfm intestinal-carriers: a randomised placebo-controlled trial. > I. Ingrid Maria Cecilia RUBIN (Hvidovre) 19:35 • 1826 • Preoperative <em>Staphylococcus aureus</em> colonisation as a risk factor for <em>Staphylococcus aureus</em> surgical site infections and postoperative bloodstream infections > D. Darren TROEMAN (Utrecht) 19:45 • 4574 • Factors associated with early deep surgical site infections following spinal fusion Instrumentation: a case-control study > B. Boun Kim TAN (Lyon) 19:55 • 3447 • The burden of nosocomial pneumonia infections involving carbapenem-non-susceptible bacteria in Europe: the pooled results of the CARBAR study > S. Simon GOLDENBERG (London) 20:05 • 3648 • VE707, a live biotherapeutic product for decolonisation of multidrug-resistant Gram-negatives as a strategy to prevent healthcare-associated infections > S. Silvia CABALLERO (Cambridge) 20:15 • 155 • Effectiveness of a care bundle to prevent non-ventilator-associated hospital-acquired pneumonia (nvHAP) > A. Aline WOLFENSBERGER (Zurich) 20:25 • INT13 • Q&A/Discussion